Analyzing 2024 Fallen Growth Stocks Part 1: Duolingo and HIMS Investment Opportunities
Many growth stocks have experienced significant declines this year. However, not all drops carry the same meaning. Today, let us dive deep into the first two of five dramatically fallen stocks: Duolingo and HIMS.
π± Duolingo: Revolutionizing Language Learning, Down 48% YTD
Strengths of the Business Model
Duolingo is more than just a language learning app. It is a global education platform with over 500 million users worldwide. Their business model is solid:
- Premium subscription model: Converting free users to paid subscribers
- Strong user engagement: High retention through gamification
- AI-powered learning: Personalized learning experiences
- Low customer acquisition cost: Natural growth through word-of-mouth
Why Did It Fall 48%?
Main reasons for the stock decline:
- Growth rate slowdown concerns: Normalization after explosive pandemic-era growth
- Valuation adjustment: Broader correction in high-valuation growth stocks
- Intensifying competition: Emergence of other language learning platforms
- Macroeconomic headwinds: Concerns about reduced consumer spending
Fundamentals Remain Strong
But looking at the actual business:
- Subscriber count still growing
- MAU (Monthly Active Users) maintaining growth trajectory
- Profitability improvements underway
- Brand power remains strong
π° What is the Right Entry Price?
An additional 15-20% drop from current levels could present an attractive entry point, especially when:
- P/S ratio falls below historical averages
- Subscriber growth rate shows signs of reacceleration
- Profitability metrics improve
When these three conditions align, it could be an excellent opportunity for long-term investors.
π HIMS: Telemedicine Leader, Down 30% in 6 Months
Innovative Business Model
HIMS & HERS Health is an innovative player in telemedicine:
- Direct-to-Consumer (DTC) model: Eliminating intermediary distribution
- Subscription-based revenue: Predictable revenue structure
- Diverse product lines: Hair loss, skin care, sexual health, mental health, etc.
- Convenience and privacy: From doctor consultations to prescriptions, all from home
Recent Stock Decline Background
- Regulatory uncertainty: Controversies around telehealth prescriptions
- Intensifying competition: Major pharmacy chains entering telemedicine
- Profitability concerns: High marketing costs
- Macro economy: Weakening consumer sentiment
Why It Still Deserves Attention
Structural growth trends:
- Telemedicine market continues to expand
- Particularly strong preference among younger generations
- Digital healthcare adoption accelerated by COVID-19
Signs of improving performance:
- Steady subscriber growth
- Successful product line diversification
- Improving unit economics
π° What is the Right Investment Price?
For HIMS, consider these conditions:
- When regulatory risks are resolved
- Confirmed upward trend in ARPU (Average Revenue Per User)
- Improved marketing efficiency (CAC/LTV ratio)
- An additional 10-15% drop from current prices
Particularly if quarterly results confirm profitability improvements and the regulatory environment stabilizes, even current price levels could be attractive.
π― Investment Checkpoints
When considering both stocks:
β Positive Factors
- Structural growth trends (language learning, telemedicine)
- Solid business models
- Strong brand recognition
- High preference among younger demographics
β οΈ Risk Factors
- High valuations (still)
- Time needed to achieve profitability
- Intensifying competition
- Macroeconomic uncertainty
π Final Thoughts
Both Duolingo and HIMS offer intriguing investment opportunities. However, it is not about buy because it is down, but rather making a rational assessment of why it fell, whether fundamentals are sound, and what is a fair price.
In the next article, we will analyze the remaining three stocks - Novo Nordisk, Lululemon, and Fiserv. Each has a unique story and investment angle, so stay tuned! πͺ
Next Posts
Analyzing 2024 Fallen Growth Stocks Part 2: Novo Nordisk, Lululemon, Fiserv Investment Strategy
Analyzing the plunge causes and fundamentals of Novo Nordisk, Lululemon, and Fiserv, and presenting investment strategies and appropriate entry prices for each stock.
The AI Chip War: Why Sell AMD and Hold Nvidia
A comparative analysis of two AI chip giants, Nvidia and AMD. While Nvidia dominates AI hardware with 80%+ market share and receives a hold rating, AMD faces a sell recommendation despite its technological capabilities due to market share gaps and slowing growth.
Tech Giants in the AI Era: Successful Transformation Strategies of Google and Adobe
An in-depth analysis of Google and Adobe AI transformation strategies. Google integrates Gemini AI into search and achieves 29% cloud growth with reasonable P/E 25x valuation. Adobe revolutionizes creative software with Firefly AI while maintaining 90%+ subscription renewal rates.
Previous Posts
Not Every Dip is a Discount: The Core of Value Investing
Is every price drop a buying opportunity? Learn about mispricing, the core of value investing, and how to identify truly undervalued stocks.
The Inheritance Secret: How Stepped-Up Basis Eliminates Capital Gains Tax
Discover the secret the wealthy use to pass fortunes tax-free across generations: the stepped-up cost basis. Learn how inherited assets reset their cost basis, eliminating capital gains tax entirely.
Never Sell Your Stocks: The Power of Securities-Backed Lending (SBLOC)
Selling stocks means tax bombs. Not selling means no cash. The wealthy solve this with SBLOCsβtax-free cash access while portfolio growth pays the interest. Learn this powerful leverage strategy.